Duane, C., Glavey, S., Quinn, J. and Murphy, P. (2020) “Significant risk of venous thromboembolism associated with targeted anti-myeloma immunomodulatory drugs. Comment on: Targeted anti-cancer agents and risk of venous thromboembolism”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2025.287442.